Group assessment
This PHI covers the named group; its members do not have separate PHI ratings.
https://dxm-atlas.org/en/interactions/mda-cathinones-serotonergic-releasers/
CompareKey points for this combination
The group’s rating is based on extrapolation from the properties of its substances. The review separately discusses an MDMA study: its CYP2D6 findings concern MDMA and do not by themselves describe the other substances in this group.
General concepts in this text
CYP2D6
One of the CYP enzymes involved in processing drugs.
Inhibition means reducing enzyme activity; it can change the processing of drugs.
Sources: CYP2D6
- IUPHAR Pharmacology Education Project: Drug metabolism · Live page accessed 2026-10-12; revision label unavailable
Extrapolation
Using information from studied groups, conditions or products to draw conclusions about other groups, conditions or products.
This relies on assumptions about how the studied and new situations are related.
Sources: Extrapolation
- EMA Reflection paper on the use of extrapolation in the development of medicines for paediatrics, Final · EMA/189724/2018; cover dated 7 October 2018, final CHMP adoption listed as 17 October 2018
How well is this understood?
Mechanism confidence: medium
Confidence in the mechanism: medium
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodConfidence in human DXM data: low
Confidence in direct human evidence involving DXM: low
M is confidence in the interaction mechanism. D is confidence in direct human findings involving DXM. Each is rated high, medium or low. D concerns what was tested under specific conditions, such as a change in drug concentration or an effect that was not found. Confidence in these findings, the PHI hazard rating and publication count are separate characteristics.
MethodHow do the substances interact?
How can the effects add up?
ⓘ
Neurotransmitter release
Movement of neurotransmitter molecules from a nerve ending into the space between cells.
During release a neurotransmitter leaves a nerve ending; during reuptake it returns into a cell.
Sources: Neurotransmitter release
- OpenStax: General Neurochemistry Principles · Introduction to Behavioral Neuroscience, published 2024-11-13
ⓘ
Autonomic nervous system
The part of the nervous system that regulates the heart, internal organs and glands without conscious control of each response.
The sympathetic division is part of this system. In a response to threat it can increase heart rate and sweating.
Sources: Autonomic nervous system
- Anatomy and Physiology 2e, §15.1 Divisions of the Autonomic Nervous System · Second edition; book publication date 20 April 2022. No separately verified webpage revision date.
Sources
Check the review’s wording
Class extrapolation; MDMA’s CYP2D6 effect cannot automatically be transferred to other substances